Page 5
|
|
Key inclusion criteria:
|
Adult patients expected to require ICU care for longer than 2 days. |
|
Update:
|
|
|
Reason:
|
|
|
Minimum Age:
|
18
Years
|
|
Update:
|
|
|
Reason:
|
|
|
Maximum Age:
|
Not stated
|
|
Update:
|
|
|
Reason:
|
|
|
Gender:
|
Both males and females |
|
Update:
|
|
|
Reason:
|
|
|
Healthy volunteers?
|
No |
|
Update:
|
|
|
Reason:
|
|
|
Key exclusion criteria:
|
1. Already tolerating an adequate oral diet;
2. Scheduled to return to oral intake within 24 hours;
3. Admitted to ICU for palliative care;
4. Moribund and not expected to survive 6 hours;
5. Brain dead or suspected to be brain dead;
6. Admitted directly to the study ICU from any other ICU. |
|
Update:
|
|
|
Reason:
|
|
Page 6
|
|
Study type: |
Interventional |
|
Update:
|
|
|
Reason:
|
|
|
Purpose of the study: |
Prevention |
|
Update:
|
|
|
Allocation to intervention: |
Randomised controlled trial |
|
Update:
|
|
|
Reason:
|
|
|
Describe the procedure for enrolling a subject and allocating the treatment (allocation concealment procedures): |
This was a cluster randomised trial. Hospitals (not patients) were randomised to implement the guideline or remain as controls. After agreeing to participate in the study, hospitals were randomised using a centralised computer program developed in SAS. |
|
Update:
|
|
|
Reason:
|
|
|
Describe the methods used to generate the sequence in which subjects will be randomised (sequence generation): |
Permuted block randomisation, stratifed by key hospital characteristics (bed number), generated using SAS. |
|
Update:
|
|
|
Reason:
|
|
|
Masking / blinding: |
Open (masking not used) |
|
Update:
|
|
|
Reason:
|
|
|
Update:
|
|
|
Reason:
|
|
|
Assignment: |
Parallel |
|
Update:
|
|
|
Reason:
|
|
|
Other design features (specify): |
Cluster randomised. Hospitals (not patients) were randomised to receive and implement and evidence-based guideline or to remain as control (no guideline) hospitals. |
|
Update:
|
|
|
Reason:
|
|
|
Type of endpoint(s): |
Efficacy |
|
Update:
|
|
|
Reason:
|
|
|
Update:
|
|
|
Reason:
|
|
|
Update:
|
|
|
Reason:
|
|
|
Update:
|
|
|
Reason:
|
|
|
Update:
|
|
|
Reason:
|
|
Page 7
|
|
Phase |
Phase 3 / Phase 4 |
|
Update:
|
|
|
Reason:
|
|
|
Anticipated or actual start date: |
1/04/2003 |
|
Update:
|
|
|
Reason:
|
|
|
Target sample size: |
1500 |
|
Update:
|
|
|
Reason:
|
|
|
Recruitment status: |
Completed |
|
Update:
|
|
|
Reason:
|
|
Page 8
|
| Funding source: | Charities/Societies/Foundations |
| Name: | ANZIC Foundation |
| Address: | Level 2, 10 Ievers Terrace - CARLTON VIC 3053 |
| Country: | Australia |
|
Primary sponsor: |
Individual |
|
Update:
|
|
|
Reason:
|
|
|
Name: |
Dr Gordon Doig |
|
Update:
|
|
|
Reason:
|
|
|
Address: |
Northern Clinical School
University of Sydney
Sydney 2006 |
|
Update:
|
|
|
Reason:
|
|
| Country:
|
Australia |
|
Update:
|
|
|
Reason:
|
|
| Secondary sponsor: | None |
| Name: | |
| Address: | |
| Country: | |
| Other collaborator: | |
Page 9
|
|
Has the study received approval from at least one ethics committee? |
Yes |
|
Update:
|
|
|
Reason:
|
|
| Ethics Committee name: | University of Sydney |
| Address: | University of Sydney
Human Research Ethics Committee,
Sydney, NSW 2006 |
| Country: | Australia |
| Date of approval: | 26/06/2003 |
| HREC Number: | 0209-150M |
| Countries of recruitment: | Australia |
|
Brief summary: |
Nutritional support is accepted as a standard of care for critically ill patients although there is little agreement as to how it is best provided. Use of evidence-based guidelines has been shown to improve the effectiveness of care. The purpose of this project is to develop, promote and evaluate evidence-based clinical practice guidelines for nutritional support in the ICU in twenty-six hospitals throughout Australia and New Zealand. One half of the hospitals will be randomised to receive educational sessions based on the content of the guidelines using previously proven and accepted educational strategies. A cluster randomised trial will then evaluate the impact of these educational sessions on acceptance of the guideline and on patient outcomes. |
|
Update:
|
|
|
Reason:
|
|
|
Trial website: |
|
|
Update:
|
|
|
Presentations / publication list: |
|
|
Update:
|
|
Page 10
|
|
Contact person for public queries
|
|
Name: |
Dr Gordon Doig |
|
Update:
|
|
|
Reason:
|
|
|
Address: |
Intensive Care Unit (ICU) Royal North Shore Hospital (RNSH) Pacific Highway St Leondards NSW 2065 |
|
Update:
|
|
|
Reason:
|
|
|
Country: |
Australia |
|
Update:
|
|
|
Reason:
|
|
|
Tel: |
+61 2 99268656 |
|
Update:
|
|
|
Reason:
|
|
|
Fax: |
+61 2 94398418 |
|
Update:
|
|
|
Reason:
|
|
|
Email: |
gdoig@med.usyd.edu.au |
|
Update:
|
|
|
Reason:
|
|
Contact person for scientific queries |
|
Name: |
Dr Gordon Doig |
|
Update:
|
|
|
Reason:
|
|
|
Address: |
Intensive Care Unit (ICU) Royal North Shore Hospital (RNSH) Pacific Highway St Leondards NSW 2065 |
|
Update:
|
|
|
Reason:
|
|
|
Country: |
Australia |
|
Update:
|
|
|
Reason:
|
|
|
Tel: |
+61 2 99268656 |
|
Update:
|
|
|
Reason:
|
|
|
Fax: |
+61 2 94398418 |
|
Update:
|
|
|
Reason:
|
|
|
Email: |
gdoig@med.usyd.edu.au |
|
Update:
|
|
|
Reason:
|
|
Contact person responsible for updating information |
|
Name: |
Dr Gordon Doig |
|
Update:
|
|
|
Reason:
|
|
|
Address: |
Intensive Care Unit (ICU) Royal North Shore Hospital (RNSH) Pacific Highway |
|
Update:
|
|
|
Reason:
|
|
|
Country: |
Australia |
|
Update:
|
|
|
Reason:
|
|
|
Tel: |
612 9926 8656 |
|
Update:
|
|
|
Reason:
|
|
|
Fax: |
612 9439 8418 |
|
Update:
|
|
|
Reason:
|
|
|
Email: |
gdoig@med.usyd.edu.au |
|
Update:
|
|
|
Reason:
|
|
|
|
|